Dendreon to Announce First Quarter 2005 Financial Results and Host Webcast Conference Call on May 9, 2005
May 02 2005 - 9:30AM
PR Newswire (US)
Dendreon to Announce First Quarter 2005 Financial Results and Host
Webcast Conference Call on May 9, 2005 SEATTLE, May 2
/PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) will
announce financial results for the first quarter 2005 after the
markets close on Monday May 9, 2005 and will hold a webcast
teleconference at 4:30 p.m. Eastern time that day. Company
management will discuss financial results from the first quarter
and provide a general corporate update. Access to the discussion
may be obtained as follows: Conference Call LIVE Access on May 9,
2005, 1:30 p.m. PT; 4:30 p.m. ET: Phone 800-289-0494 (domestic) or
+1-913-981-5520 (international); Webcast connection is available
through the "Investors/Webcast & Presentations" section of
Dendreon's website at http://www.dendreon.com/. REPLAY Access:
Phone replay is available for 3 days by calling 888-203-1112
(domestic) or +1-719-457-0820 (international). Passcode: 4171290
Webcast replay is available for 90 days through the
"Investors/Webcast & Presentations" section of Dendreon's
website at http://www.dendreon.com/. Dendreon Corporation is a
biotechnology company whose mission is to target cancer and
transform lives through the development of innovative cancer
treatments. In addition to its immunotherapies in clinical and
preclinical development for a variety of cancers, Dendreon's
product pipeline also includes monoclonal antibody and small
molecule product candidates. Dendreon has research and development
alliances with Genentech, Inc., Abgenix, Inc. and Dyax Corp. For
more information about the company and its programs, visit
http://www.dendreon.com/. DATASOURCE: Dendreon Corporation CONTACT:
Monique M. Greer, Sr. Director, Corporate Communications of
Dendreon Corporation, +1-206-829-1500 Web site:
http://www.dendreon.com/
Copyright